ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Life sciences professional Peter Marchesini joins Indegene to help clients improve commercial outcomes

PRINCETON, N.J. and BENGALURU, India, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, today announced the appointment of Peter Marchesini as Senior Vice President to help life sciences companies improve the effectiveness and efficiency of their commercial processes and go-to-market approach.

Peter brings more than 30 years of experience in the life sciences industry. Most recently, he was President of Field Solutions at Eversana. Prior to that, he was the Cofounder and Chief Operating Officer of Alamo Pharma Services. Earlier, Peter served as the Executive Director of Sales and Chief Learning Officer of inVentiv Health, and a member of its steering committee. Peter continues to serve on the faculty of Rutgers Business School Pharmaceutical MBA program and is a three-time honoree of PharmaVoice Magazine’s 100 Most Inspiring Leaders.

At Indegene, Peter will drive strategic client engagement with a focus on the commercial segment of the life sciences value chain. Indegene combines healthcare expertise with data, analytics and insights based on the digital affinity of healthcare professionals, to help life sciences companies personalize their omnichannel experience and improve the effectiveness of their sales efforts.

“Life sciences companies seek operational agility and innovative go-to-market models to enhance their competitiveness. With our digital-first capabilities and healthcare expertise, we are committed to helping clients personalize the experience for patients and physicians across channels,” said Gaurav Kapoor, Executive Vice President of Indegene, Inc. “I am excited to welcome Peter onboard and look forward to helping our clients be future ready.”

“I am inspired by Indegene’s consistent growth, stable leadership, and strong client relationships over the years. I look forward to working with clients to fully realize their commercialization potential through our digital-first approach,” said Peter Marchesini, Senior Vice President, Indegene. “I am thrilled to join Indegene and help life sciences companies evolve their go-to-market strategy and optimize impact through an omnichannel approach.”

About Indegene
We are a digital-first, life sciences commercialization company. We help biopharmaceutical, emerging biotech, and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient, and modern way. We bring together healthcare domain expertise, fit-for-purpose technology, and an agile operating model to provide a diverse range of solutions. These aim to deliver, amongst other outcomes, a personalized, scalable, and omnichannel experience for patients and physicians. It’s what drives our team and our purpose to enable healthcare organizations to be future ready. To learn more, please visit www.indegene.com

For media inquiries, please contact:
Yadunandan K V | yadunandan.kv@indegene.com


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.